Cargando…

Insulin induces a progressive increase in the resistance of subcutaneous tissue to fluid flow: Implications for insulin pump therapy

AIM: To determine the effect of insulin on the resistance of subcutaneous tissue to the flow of infusion fluids. MATERIALS AND METHODS: Thirty subjects with type 1 diabetes wore two Accu‐Chek Spirit Combo insulin pumps with Accu‐Chek FlexLink infusion sets (Roche Diabetes Care, Mannheim, Germany) fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Regittnig, Werner, Tschaikner, Mathias, Tuca, Alexandru‐Cristian, Simic, Amra, Feiel, Jürgen, Schaller‐Ammann, Roland, Licht, Alexander H., Jungklaus, Miró, Pieber, Thomas R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299465/
https://www.ncbi.nlm.nih.gov/pubmed/34739179
http://dx.doi.org/10.1111/dom.14594
_version_ 1784750981668405248
author Regittnig, Werner
Tschaikner, Mathias
Tuca, Alexandru‐Cristian
Simic, Amra
Feiel, Jürgen
Schaller‐Ammann, Roland
Licht, Alexander H.
Jungklaus, Miró
Pieber, Thomas R.
author_facet Regittnig, Werner
Tschaikner, Mathias
Tuca, Alexandru‐Cristian
Simic, Amra
Feiel, Jürgen
Schaller‐Ammann, Roland
Licht, Alexander H.
Jungklaus, Miró
Pieber, Thomas R.
author_sort Regittnig, Werner
collection PubMed
description AIM: To determine the effect of insulin on the resistance of subcutaneous tissue to the flow of infusion fluids. MATERIALS AND METHODS: Thirty subjects with type 1 diabetes wore two Accu‐Chek Spirit Combo insulin pumps with Accu‐Chek FlexLink infusion sets (Roche Diabetes Care, Mannheim, Germany) for 7 days. One pump was filled with insulin aspart (Novo Nordisk, Bagsvaerd, Denmark) and used for continuous subcutaneous insulin infusion (CSII). The other pump was filled with insulin diluting medium (IDM; Novo Nordisk) and used to deliver IDM subcutaneously at rates identical to those employed for CSII. Both infusion sites were assessed daily by measuring the pressure required to infuse various bolus amounts of IDM. RESULTS: On day 1, maximum pressure (P(max)) and tissue flow resistance (TFR; calculated from measured pressure profiles) were similar for both infusion sites (P > 0.20). During the subsequent study days, the P(max) and TFR values observed at the IDM infusion site remained at levels comparable to those seen on day 1 (P > 0.13). However, at the site of CSII, P(max) and TFR progressively increased with CSII duration. By the end of day 7, P(max) and TFR reached 25.8 */2.11 kPa (geometric mean */geometric standard deviation) and 8.64 */3.48 kPa*s/μL, respectively, representing a remarkable 3.5‐ and 20.6‐fold increase relative to the respective P(max) and TFR values observed on day 1 (P < 0.001). CONCLUSION: Our results suggest that insulin induces a progressive increase in the resistance of subcutaneous tissue to the introduction of fluid; this has important implications for the future design of insulin pumps and infusion sets.
format Online
Article
Text
id pubmed-9299465
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Blackwell Publishing Ltd
record_format MEDLINE/PubMed
spelling pubmed-92994652022-07-21 Insulin induces a progressive increase in the resistance of subcutaneous tissue to fluid flow: Implications for insulin pump therapy Regittnig, Werner Tschaikner, Mathias Tuca, Alexandru‐Cristian Simic, Amra Feiel, Jürgen Schaller‐Ammann, Roland Licht, Alexander H. Jungklaus, Miró Pieber, Thomas R. Diabetes Obes Metab Original Articles AIM: To determine the effect of insulin on the resistance of subcutaneous tissue to the flow of infusion fluids. MATERIALS AND METHODS: Thirty subjects with type 1 diabetes wore two Accu‐Chek Spirit Combo insulin pumps with Accu‐Chek FlexLink infusion sets (Roche Diabetes Care, Mannheim, Germany) for 7 days. One pump was filled with insulin aspart (Novo Nordisk, Bagsvaerd, Denmark) and used for continuous subcutaneous insulin infusion (CSII). The other pump was filled with insulin diluting medium (IDM; Novo Nordisk) and used to deliver IDM subcutaneously at rates identical to those employed for CSII. Both infusion sites were assessed daily by measuring the pressure required to infuse various bolus amounts of IDM. RESULTS: On day 1, maximum pressure (P(max)) and tissue flow resistance (TFR; calculated from measured pressure profiles) were similar for both infusion sites (P > 0.20). During the subsequent study days, the P(max) and TFR values observed at the IDM infusion site remained at levels comparable to those seen on day 1 (P > 0.13). However, at the site of CSII, P(max) and TFR progressively increased with CSII duration. By the end of day 7, P(max) and TFR reached 25.8 */2.11 kPa (geometric mean */geometric standard deviation) and 8.64 */3.48 kPa*s/μL, respectively, representing a remarkable 3.5‐ and 20.6‐fold increase relative to the respective P(max) and TFR values observed on day 1 (P < 0.001). CONCLUSION: Our results suggest that insulin induces a progressive increase in the resistance of subcutaneous tissue to the introduction of fluid; this has important implications for the future design of insulin pumps and infusion sets. Blackwell Publishing Ltd 2021-11-17 2022-03 /pmc/articles/PMC9299465/ /pubmed/34739179 http://dx.doi.org/10.1111/dom.14594 Text en © 2021 The Authors. Diabetes, Obesity and Metabolism published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Articles
Regittnig, Werner
Tschaikner, Mathias
Tuca, Alexandru‐Cristian
Simic, Amra
Feiel, Jürgen
Schaller‐Ammann, Roland
Licht, Alexander H.
Jungklaus, Miró
Pieber, Thomas R.
Insulin induces a progressive increase in the resistance of subcutaneous tissue to fluid flow: Implications for insulin pump therapy
title Insulin induces a progressive increase in the resistance of subcutaneous tissue to fluid flow: Implications for insulin pump therapy
title_full Insulin induces a progressive increase in the resistance of subcutaneous tissue to fluid flow: Implications for insulin pump therapy
title_fullStr Insulin induces a progressive increase in the resistance of subcutaneous tissue to fluid flow: Implications for insulin pump therapy
title_full_unstemmed Insulin induces a progressive increase in the resistance of subcutaneous tissue to fluid flow: Implications for insulin pump therapy
title_short Insulin induces a progressive increase in the resistance of subcutaneous tissue to fluid flow: Implications for insulin pump therapy
title_sort insulin induces a progressive increase in the resistance of subcutaneous tissue to fluid flow: implications for insulin pump therapy
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299465/
https://www.ncbi.nlm.nih.gov/pubmed/34739179
http://dx.doi.org/10.1111/dom.14594
work_keys_str_mv AT regittnigwerner insulininducesaprogressiveincreaseintheresistanceofsubcutaneoustissuetofluidflowimplicationsforinsulinpumptherapy
AT tschaiknermathias insulininducesaprogressiveincreaseintheresistanceofsubcutaneoustissuetofluidflowimplicationsforinsulinpumptherapy
AT tucaalexandrucristian insulininducesaprogressiveincreaseintheresistanceofsubcutaneoustissuetofluidflowimplicationsforinsulinpumptherapy
AT simicamra insulininducesaprogressiveincreaseintheresistanceofsubcutaneoustissuetofluidflowimplicationsforinsulinpumptherapy
AT feieljurgen insulininducesaprogressiveincreaseintheresistanceofsubcutaneoustissuetofluidflowimplicationsforinsulinpumptherapy
AT schallerammannroland insulininducesaprogressiveincreaseintheresistanceofsubcutaneoustissuetofluidflowimplicationsforinsulinpumptherapy
AT lichtalexanderh insulininducesaprogressiveincreaseintheresistanceofsubcutaneoustissuetofluidflowimplicationsforinsulinpumptherapy
AT jungklausmiro insulininducesaprogressiveincreaseintheresistanceofsubcutaneoustissuetofluidflowimplicationsforinsulinpumptherapy
AT pieberthomasr insulininducesaprogressiveincreaseintheresistanceofsubcutaneoustissuetofluidflowimplicationsforinsulinpumptherapy